Figure 4
From: Multi-cohort study on cytokine and chemokine profiles in the progression of COVID-19
Dynamic trends in cytokine and chemokine levels during disease progression in patients with COVID-19, (A) Schematic diagram illustrating patients undergoing a mild-to-severe transition to COVID-19. (B-H) Plasma levels of IL-16, IL-18, IL-6, IL-10, IP-10, TRAIL, and SCGF-β in patients with mild, progressive, and severe COVID-19. The p value was calculated using paired two-sided Student’s t tests. *P < 0.05, **P < 0.01.
